CKD Bio Corp. (063160) Price & Analysis

― Followers

063160 Stock Chart & Stats

$12200.00

-$820.00(-6.30%)

Jul 29, 2026

―

Day’s Range― - ―

52-Week Range$12,150.00 - $24,900.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩71.43B

Enterprise Value$249.52K

Total Cash (Recent Filing)₩1.03B

Total Debt (Recent Filing)₩147.68B

Price to Earnings (P/E)―

Beta0.23

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1059.55

Shares Outstanding5,485,962

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio0.29

Price to Book (P/B)0.88

Price to Sales (P/S)0.70

P/FCF Ratio-10.20

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

063160 FAQ

What was CKD Bio Corp.’s price range in the past 12 months?

CKD Bio Corp. lowest stock price was $12150.00 and its highest was $24900.00 in the past 12 months.

What is CKD Bio Corp.’s market cap?

CKD Bio Corp.’s market cap is ₩71.43B.

When is CKD Bio Corp.’s upcoming earnings report date?

CKD Bio Corp.’s upcoming earnings report date is Aug 18, 2026 which is in 19 days.

How were CKD Bio Corp.’s earnings last quarter?

CKD Bio Corp. released its earnings results on May 15, 2026. The company reported -$369.87 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is CKD Bio Corp. overvalued?

According to Wall Street analysts CKD Bio Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does CKD Bio Corp. pay dividends?

CKD Bio Corp. does not currently pay dividends.

What is CKD Bio Corp.’s EPS estimate?

CKD Bio Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does CKD Bio Corp. have?

CKD Bio Corp. has 5,485,962 shares outstanding.

What happened to CKD Bio Corp.’s price movement after its last earnings report?

CKD Bio Corp. reported an EPS of -$369.87 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.543%.

Which hedge fund is a major shareholder of CKD Bio Corp.?

Currently, no hedge funds are holding shares in KR:063160

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

CKD Bio Corp.

CKD Bio Corp., a South Korean company founded in 1941 and headquartered in Seoul, specializes in the production and distribution of pharmaceutical active ingredients (APIs). Their manufacturing processes leverage diverse technologies, including fermentation, chemical synthesis, and biotechnology. The company's extensive portfolio of APIs targets a broad spectrum of therapeutic applications, encompassing antibiotics, beta-lactamase inhibitors, immunosuppressants, oncology treatments, anti-obesity medications, dry eye remedies, antiviral and antituberculosis agents, antihyperlipidemics, and probiotics. Beyond its core manufacturing, CKD Bio Corp. also provides contract research, development, and manufacturing (CRDMO) services for APIs, pharmaceutical intermediates, and probiotic formulations. The company actively exports its products, establishing a global reach.